Individual differences in chromosomal aberrations after in vitro irradiation of cells from healthy individuals, cancer and cancer susceptibility syndrome patients

Radiotherapy and Oncology

Volumn 81, Issue 3, 2006, Pages 257-263

  Distel, Luitpold V R ^a   Neubauer, Susann ^a   Keller, Ulrike ^a   Sprung, Carl N ^b   Sauer, Rolf ^a   Grabenbauer, Gerhard G ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b PETER MACCALLUM CANCER CENTRE   (Australia)

Author keywords

ATM; Cancer patients; Cancer risk; Chromosomal aberrations; Individual sensitivity; NBS1

Indexed keywords

ATM PROTEIN; NIBRIN;

ARTICLE; CANCER; CANCER GENETICS; CANCER INCIDENCE; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SUSCEPTIBILITY; CHROMOSOME ABERRATION; CHROMOSOME BREAKAGE; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HETEROZYGOTE; HOMOZYGOTE; HUMAN; HYPERSENSITIVITY; IN VITRO STUDY; IRRADIATION; MALE; METAPHASE CHROMOSOME; NORMAL DISTRIBUTION; PRIORITY JOURNAL; RADIOSENSITIVITY; SAMPLE;

CELL CYCLE PROTEINS; CELLS, CULTURED; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN; DISEASE SUSCEPTIBILITY; DNA-BINDING PROTEINS; FEMALE; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; METAPHASE; NEOPLASMS; NUCLEAR PROTEINS; PROTEIN-SERINE-THREONINE KINASES; RADIATION TOLERANCE; SYNDROME; TUMOR SUPPRESSOR PROTEINS;

EID: 33845243592     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2006.10.012     Document Type: Article

References (32)

1. Baeyens A., Thierens H., Claes K., et al. Chromosomal radiosensitivity in breast cancer patients with a known or putative genetic predisposition. Br J Cancer 87 (2002) 1379-1385
2. Baria K., Warren C., Roberts S.A., et al. Chromosomal radiosensitivity as a marker of predisposition to common cancers?. Br J Cancer 84 (2001) 892-896
3. Becker-Catania S.G., Chen G., Hwang M.J., et al. Ataxia-telangiectasia: phenotype/genotype studies of ATM protein expression, mutations, and radiosensitivity. Mol Genet Metab 70 (2000) 122-133
4. Brogger A., Hagmar L., Hansteen I.L., et al. An inter-Nordic prospective study on cytogenetic endpoints and cancer risk. Nordic Study Group on the Health Risk of Chromosome Damage. Cancer Genet Cytogenet 45 (1990) 85-92
5. Burnet N.G., Johansen J., Turesson I., et al. Describing patients' normal tissue reactions: concerning the possibility of individualising radiotherapy dose prescriptions based on potential predictive assays of normal tissue radiosensitivity. Steering Committee of the BioMed2 European Union Concerted Action Programme on the Development of Predictive Tests of Normal Tissue Response to Radiation Therapy. Int J Cancer 79 (1998) 606-613
6. Chen P.C., Lavin M.F., Kidson C., et al. Identification of ataxia telangiectasia heterozygotes, a cancer prone population. Nature 274 (1978) 484-486
7. Chun H.H., and Gatti R.A. Ataxia-telangiectasia, an evolving phenotype. DNA Repair (Amst) 3 (2004) 1187-1196
8. Dikomey E., Borgmann K., Peacock J., et al. Why recent studies relating normal tissue response to individual radiosensitivity might have failed and how new studies should be performed. Int J Radiat Oncol Biol Phys 56 (2003) 1194-1200
9. Distel L., Neubauer S., Varon R., et al. Fatal toxicity following radio- and chemotherapy of medulloblastoma in a child with unrecognized Nijmegen breakage syndrome. Med Pediatr Oncol 41 (2003) 44-48
10. Goodarzi A.A., and Lees-Miller S.P. Biochemical characterization of the ataxia-telangiectasia mutated (ATM) protein from human cells. DNA Repair (Amst) 3 (2004) 753-767
11. Hagmar L., Brogger A., Hansteen I.L., et al. Cancer risk in humans predicted by increased levels of chromosomal aberrations in lymphocytes: Nordic study group on the health risk of chromosome damage. Cancer Res 54 (1994) 2919-2922
12. Hagmar L., Stromberg U., Bonassi S., et al. Impact of types of lymphocyte chromosomal aberrations on human cancer risk: results from Nordic and Italian cohorts. Cancer Res 64 (2004) 2258-2263
13. Hoeller U., Borgmann K., Bonacker M., et al. Individual radiosensitivity measured with lymphocytes may be used to predict the risk of fibrosis after radiotherapy for breast cancer. Radiother Oncol 69 (2003) 137-144
14. Keller U., Grabenbauer G., Kuechler A., et al. Radiation sensitivity testing by FISH: how many metaphases have to be analysed?. Int J Radiat Biol 80 (2004) 615-620
15. Keller U., Grabenbauer G., Kuechler A., et al. Cytogenetic instability in young patients with multiple primary cancers. Cancer Genet Cytogenet 157 (2005) 25-32
16. Keller U., Kuechler A., Liehr T., et al. Impact of various parameters in detecting chromosomal aberrations by FISH to describe radiosensitivity. Strahlenther Onkol 180 (2004) 289-296
17. Kruger L., Demuth I., Neitzel H., et al. Cancer incidence in Nijmegen breakage syndrome is modulated by the amount of a variant NBS protein. Carcinogenesis (2006)
18. Meyn M.S. Ataxia-telangiectasia, cancer and the pathobiology of the ATM gene. Clin Genet 55 (1999) 289-304
19. Neubauer S., Arutyunyan R., Stumm M., et al. Radiosensitivity of ataxia telangiectasia and Nijmegen breakage syndrome homozygotes and heterozygotes as determined by three-color FISH chromosome painting. Radiat Res 157 (2002) 312-321
20. Neubauer S., Dunst J., and Gebhart E. The impact of complex chromosomal rearrangements on the detection of radiosensitivity in cancer patients. Radiother Oncol 43 (1997) 189-195
21. Papworth R., Slevin N., Roberts S.A., et al. Sensitivity to radiation-induced chromosome damage may be a marker of genetic predisposition in young head and neck cancer patients. Br J Cancer 84 (2001) 776-782
22. Pisani P., Parkin D.M., Bray F., et al. Estimates of the worldwide mortality from 25 cancers in 1990. Int J Cancer 83 (1999) 18-29
23. Riches A.C., Bryant P.E., Steel C.M., et al. Chromosomal radiosensitivity in G2-phase lymphocytes identifies breast cancer patients with distinctive tumour characteristics. Br J Cancer 85 (2001) 1157-1161
24. Scott D. Chromosomal radiosensitivity and low penetrance predisposition to cancer. Cytogenet Genome Res 104 (2004) 365-370
25. Scott D., Spreadborough A., Levine E., et al. Genetic predisposition in breast cancer. Lancet 344 (1994) 1444
26. Sedgwick R.P., and Boder E. Ataxia telangiectasia (1991), Elsevier, New York
27. Shiloh Y. ATM and related protein kinases: safeguarding genome integrity. Nat Rev Cancer 3 (2003) 155-168
28. Shiloh Y., Parshad R., Sanford K.K., et al. Carrier detection in ataxia-telangiectasia. Lancet 1 (1986) 689-690
29. Tauchi H., Matsuura S., Kobayashi J., et al. Nijmegen breakage syndrome gene, NBS1, and molecular links to factors for genome stability. Oncogene 21 (2002) 8967-8980
30. Vineis P. Individual susceptibility to carcinogens. Oncogene 23 (2004) 6477-6483
31. Windschall A., Ott O.J., Sauer R., et al. Radiation therapy and simultaneous chemotherapy for recurrent cervical carcinoma. Strahlenther Onkol 181 (2005) 545-550
32. Wistop A., Keller U., Sprung C.N., et al. Individual radiosensitivity does not correlate with radiation-induced apoptosis in lymphoblastoid cell lines or CD3+ lymphocytes. Strahlenther Onkol 181 (2005) 326-335